|
Estimated five-year commitment in US$ to 71 countries (March 2005)
Country |
Surviving Infants at first approval |
DTP3 coverage at first approval |
5 years Immunization Services Support |
3 years Injection safety support |
5 years New and Under-used vaccine Support |
Vaccine presentation |
Other support |
Total commitment for five years |
Afghanistan | 901,328 | 31% |
8,869,500 | 1,619,000 | | | | 10,488,500
| Albania | 60,000 | 93% | | 103,000 |
348,000 | hepB (10ds) |
100,000 | 551,000 | Angola | 623,114 | 50% | 6,565,500 |
1,508,500 | | | | 8,074,000
| Armenia | 36,118 | 63% | 80,000 |
54,500 | 351,000 | hepB
(1ds) | 100,000 |
585,500 | Azerbaijan | 106,250 | 72% |
496,500 | 145,000 |
692,500 | hepB (10ds & 2ds) |
100,000 | 1,434,000 | Bangladesh | 3,662,915 | 67% | 34,968,000
| 8,204,500 |
24,916,000 | hepB (10ds) |
100,000 | 68,188,500 | Benin | 240,517 | 61% | | 438,000 |
20,574,000 | YF & hepB (10), to
DTP-HepB+Hib (2005) | 100,000 |
21,112,000 | Bhutan | 15,902 | 88% | | 25,500 |
355,500 | DTP-hepB 2003; |
100,000 | 481,000 | Bolivia | 202,677 | 93% | | 665,000 | | | | 665,000
| Bosnia & Herz | 39,633 | 85% | | | 252,500 | hepB
(1ds & 10ds) | 100,000 |
352,500 | Burkina
Faso | 456,000 | 42% |
5,586,000 | 991,500 |
40,524,000 | DTP-HepB+Hib (2006) |
100,000 | 47,201,500 | Burundi | 261,669 | 57% | 2,662,500 |
428,000 | 19,881,500 | DTP-Hib & hepB (2004); then
DTP-hepB+Hib | 100,000 |
23,072,000 | Cambodia | 434,774 | 65% |
2,392,000 | 667,500 |
10,017,500 | DTP-hepB | 100,000 |
13,177,000 | Cameroon | 594,855 | 48% |
5,505,000 | 1,082,500 |
20,708,000 | YF, DTP-Hep B | 100,000 | 27,395,500
| CAR | 131,612 | 23% | 1,837,000 |
156,000 | 630,000 | YF
| 100,000 |
2,723,000 | Chad | 287,769 | 32% |
2,716,000 | 421,500 |
1,063,000 | YF | 100,000 |
4,300,500 | China |
19,107,468 | 93% | | 15,926,000
| 21,953,500 | hepB
(1ds) | 800,000 |
38,679,500 | Comoros | 21,376 | 67% |
141,000 | 32,500 | 352,000 | hepB
(10ds) to DTP-HepB (2005) | 100,000 | 625,500
| Congo Rep | 141,266 | 50% |
1,534,500 | 266,500 |
796,500 | YF | 100,000 |
2,697,500 | Congo DRC | 2,425,327 | 31% | 31,299,000
| 3,238,000 |
14,445,500 | YF | 100,000 |
49,082,500 | Côte
d’Ivoire | 468,276 | 56% |
3,860,500 | | 9,397,000 | DTP-hepB | 100,000 |
13,357,500 | Djibouti | 24,762 | 53% |
271,000 | 32,000 | | | | 303,000
| Eritrea | 97,846 | 61% | 729,500 |
145,500 | 2,010,000 | DTP-hepB | 100,000 |
2,985,000 | Ethiopia | 2,532,519 | 45% | 15,593,500
| 3,091,000 | | | | 18,684,500
| Gambia | 51,840 | 74% | 388,500 |
109,000 | 3,281,000 | hepB(10ds) & DTP-Hib(10ds) &
Hib(10ds) | 100,000 |
3,878,500 | Georgia | 50,776 | 61% |
273,500 | 60,000 | 597,500 | hepB
(6ds) | 100,000 |
1,031,000 | Ghana | 779,359 | 73% |
2,323,500 | 855,000 |
49,994,000 | DTP-hepB+Hib & YF |
100,000 | 53,272,500 | Guinea | 288,702 | 57% | 2,100,500 |
645,500 | 1,044,000 | YF | 100,000 |
3,890,000 | Guinea
Bissau | 43,500 | 47% |
423,000 | 126,500 | | | | 549,500
| Guyana | 20,414 | 83% | | | 932,000 | DTP-hepB+Hib |
100,000 | 1,032,000 | Haiti | 262,500 | 59% | 2,171,500 |
494,000 | | | | 2,665,500
| Honduras | 187,704 | 98% | | 471,000 | | | | 471,000
| India | 24,460,000 | 55% | | 24,201,500
| 15,698,500 | hepB
(10ds) (2002-03) + (2005-07) |
100,000 | 40,000,000 | Indonesia |
4,570,828 | 90% | 16,005,000
| 10,745,500 |
13,249,500 | hepB Uniject |
100,000 | 40,100,000 | Kenya | 1,285,300 | 64% | 11,113,000
| 1,244,500 |
67,215,000 | DTP-hepB+Hib & YF |
100,000 | 79,672,500 | Korea
DPR | 441,096 | 63% |
3,315,500 | 761,000 |
2,904,000 | hepB (10ds) |
100,000 | 7,080,500 | Kyrgyz Rep | 98,637 | 99% | | 178,000 |
1,091,500 | hepB (1ds & 6ds) |
100,000 | 1,369,500 | Lao
PDR | 180,000 | 56% |
2,251,500 | 279,000 |
5,564,000 | DTP-hepB | 100,000 |
8,194,500 | Lesotho | 64,324 | 56% |
517,000 | 109,500 |
384,500 | hepB (10ds) |
100,000 | 1,111,000 | Liberia | 147,540 | 23% | 2,804,500 | | 734,000 | YF | 100,000 |
3,638,500 | Madagascar | 588,315 | 57% |
4,278,000 | | 12,133,000
| DTP-hepB | 100,000 |
16,511,000 | Malawi | 393,539 | 83% | | | 33,082,500
| DTP-hepB+Hib |
100,000 | 33,182,500 | Mali | 391,620 | 45% | 4,524,000 |
745,000 | 27,114,000 | YF &
hepB (10), to DTP-HepB+Hib (2005) |
100,000 | 32,483,000 | Mauritanie | 106,768 | 61% |
1,062,500 | 203,500 |
825,000 | hepB (10) |
100,000 | 2,191,000 | Moldova | 41,100 | 98% | | 86,500 |
343,500 | hepB (2ds) |
100,000 | 530,000 | Mongolia | 43,700 | 98% | | 109,000 |
3,235,000 | Phased DTP-hepB+Hib |
100,000 | 3,444,000 | Mozambique | 672,000 | 73% |
3,292,000 | 941,000 |
15,855,500 | DTP-hepB | 100,000 |
20,188,500 | Myanmar | 1,271,239 | 70% | 6,994,500 |
2,674,000 | 20,146,000 | hepB
(1ds & 6ds) | 100,000 |
29,914,500 | Nepal | 727,764 | 72% |
5,147,000 | 1,353,500 |
12,490,000 | hepB (10ds) to DTP-HepB (2005)
| 100,000 |
19,090,500 | Nicaragua | 168,849 | 86% | | 439,500 | | | | 439,500
| Niger | 484,000 | 23% | 5,731,500 |
994,000 | | | | 6,725,500
| Nigeria | 4,608,972 | 38% | 53,020,500
| |
27,729,500 | YF | 100,000 |
80,850,000 | Pakistan | 4,878,000 | 58% | 31,943,500
| 9,510,000 |
30,729,000 | hepB (10ds) |
100,000 | 72,282,500 | Rwanda | 326,886 | 57% | 3,512,000 |
369,000 | 21,095,000 | DTP-hepB+Hib |
100,000 | 25,076,000 | São
Tome | 5,651 | 79% |
63,000 | 11,000 | 79,000 | hepB
(10); YF | 100,000 |
253,000 | Senegal | 418,091 | 52% |
4,981,000 | 749,500 |
22,472,000 | hepB; DTP-HepB+Hib (2005)
| 100,000 | 28,302,500
| Sierra Leone | 166,464 | 39% |
2,310,500 | 312,500 |
788,500 | YF | 100,000 |
3,511,500 | Somalia | 270,769 | 30% |
3,399,500 | 311,000 | | | | 3,710,500
| Sri Lanka | 322,366 | 99% | | 779,500 |
2,841,000 | hepB (2ds & 10ds) 2003 |
100,000 | 3,720,500 | Sudan | 1,029,179 | 64% | 8,967,500 |
1,828,000 | 4,461,500 | hep
B | 100,000 | 15,357,000
| Tajikistan | 155,283 | 65% |
1,322,500 | 358,500 |
873,500 | hepB (1ds & 10ds) |
100,000 | 2,654,500 | Tanzania | 1,279,401 | 74% | 8,328,000 |
1,495,500 | 30,807,500 | DTP-hepB | 100,000 |
40,731,000 | Togo | 196,240 | 43% |
1,945,000 | 374,500 |
1,038,500 | YF | 100,000 |
3,458,000 | Turkmenistan | 94,818 | 96% | | 149,500 |
792,500 | hepB (1ds & 10ds) |
100,000 | 1,042,000 | Uganda | 968,155 | 54% | 10,844,000
| 1,338,000 |
79,804,500 | DTP-hepB+Hib 2002 |
100,000 | 92,086,500 | Ukraine | 395,196 | 97% | | 761,500 |
3,021,000 | hepB (1ds & 10ds) |
100,000 | 3,882,500 | Uzbekistan | 533,484 | 95% | | 807,500 |
3,624,500 | hepB (10ds) |
100,000 | 4,532,000 | Viet
Nam | 1,577,046 | 93% | | 3,296,500 |
11,282,500 | hepB (1ds & 2ds) |
100,000 | 14,679,000 | Yemen | 592,436 | 73% | 4,341,500 |
1,238,000 | 52,900,500 | DTP-hepB+Hib |
100,000 | 58,580,000 | Zambia | 427,524 | 75% | 4,689,500 |
762,500 | 43,914,500 | DTP-Hib (2004); then
DTP-hepB+Hib | 100,000 |
49,466,500 | Zimbabwe | 380,394 | 78% |
3,220,000 | 1,188,000 | | | | 4,408,000
| TOTAL | 89,321,742 | | 342,711,500 | 112,708,000 | 815,437,000 | | 6,600,000 | 1,277,456,500 |
|